Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATLiver: Atorvastatin in Liver Cirrhosis
NCT04072601Phase 4Terminated
- Sponsor
- Rigshospitalet
- Start
- Nov 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in Liver cirrhosis (LC), sponsored by Rigshospitalet. Started Nov 2019; status: terminated.
02
Drugs
atorvastatin
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT04072601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072601.